Monitoring long-term effects of SARS-CoV-2 infections
Long-term Sequelae of Severe Sars-CoV-2 Infections
This study follows patients who were hospitalized with COVID-19 to see how the virus has affected their lungs and heart over the long term.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 120 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Giessen Academic / other |
| Locations | 1 site (Giessen) |
| Trial ID | NCT04442789 on ClinicalTrials.gov |
What this trial studies
This observational investigation follows patients who have been hospitalized due to SARS-CoV-2 infections to monitor the long-term effects on various organs, particularly focusing on the lungs and cardiovascular system. The study aims to assess the persistence of organ damage and the need for ongoing medical care in these patients. By analyzing the sequelae of COVID-19, the research seeks to understand the broader implications of the virus beyond the acute phase of the infection.
Who should consider this trial
Good fit: Ideal candidates for this study are adults who have been hospitalized due to a SARS-CoV-2 infection.
Not a fit: Patients under 18 years of age will not benefit from this study as they are excluded from participation.
Why it matters
Potential benefit: If successful, this study could provide critical insights into the long-term health impacts of COVID-19, guiding better post-infection care and management strategies.
How similar studies have performed: Other studies have reported on the long-term effects of COVID-19, indicating that this area of research is gaining traction and has shown some success in understanding post-viral sequelae.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * hospitalization due to Sars-CoV-2 infection Exclusion Criteria: * under 18 years of age
Where this trial is running
Giessen
- Department of Internal Medicine II, Universities of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University — Giessen, Germany (Recruiting)
Study contacts
- Study coordinator: Ulrich Matt, MD, PhD
- Email: ulrich.matt@innere.med.uni-giessen.de
- Phone: 0049-(0)641-985-58773
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.